Hcv Clearance And Pro-Thrombotic Shift In Advanced Liver Disease

Introduction: Hepatitis C virus (HCV) infection is associated to an increased risk of cardiovascular-disease (CVD) and thromboembolic-events. Direct-acting-antiviral (DAA) agents have an excellent safety profile and induce HCV viral clearance in almost all treated patients, but their impact on CVD risk remains unclear. Platelet activation and oxidative stress play a crucial role on the onset of thrombosis and CVD.